From the Dr. Kiran C. Patel College of Allopathic Medicine (W.W., A.A.R.), Nova Southeastern University, Davie, Florida
From the Dr. Kiran C. Patel College of Allopathic Medicine (W.W., A.A.R.), Nova Southeastern University, Davie, Florida.
AJNR Am J Neuroradiol. 2021 Dec;42(12):2175-2180. doi: 10.3174/ajnr.A7332. Epub 2021 Nov 4.
For patients with large-vessel occlusion, mechanical thrombectomy (MT) without IV-tPA is a proved strategy. The relative benefit of direct MT versus MT+IV-tPA for patients with indications for IV-tPA is being actively investigated. We used a national inpatient database to assess trends in use and patient profiles after MT+IV-tPA versus mechanical thrombectomy alone.
The National Inpatient Sample was queried between 2013 and 2018 for patients undergoing mechanical thrombectomy for acute ischemic stroke. Patients who received mechanical thrombectomy alone were compared with those who underwent MT+IV-tPA. The Cochran-Armitage test was conducted to assess the linear trend of use of mechanical thrombectomy alone among the entire cohort and between admissions involving non-White and White patients. All estimates were nationalized using discharge weights.
A total of 89,645 weighted admissions were identified pertaining to mechanical thrombectomy for acute ischemic stroke from 2013 to 2018. Of these, 59,935 (66.9%) admissions involved mechanical thrombectomy alone. There was an increase in the trend toward the use of mechanical thrombectomy alone (trend: 3.26%; < .001) per year. Multivariable regression analysis regarding patient profiles indicated that patients who identified as Black (OR = 0.83, = .001) or Hispanic (OR = 0.79; < .001) were more likely to undergo mechanical thrombectomy alone compared with those who identified as White. There was no statistically significant difference in the slope between non-White and White populations receiving mechanical thrombectomy alone (trend: +0.93% in favor of non-White; = .096).
Our results indicated that mechanical thrombectomy alone was used more frequently than MT+IV-tPA among patients with acute ischemic stroke. The disparity between those who identify as White and non-White persisted across the years, though it is closing.
对于大血管闭塞的患者,机械取栓(MT)联合 IV-tPA 治疗是一种已被证实的策略。对于适合 IV-tPA 的患者,直接 MT 与 MT+IV-tPA 的相对获益正在积极研究中。我们使用全国性住院患者数据库评估 MT+IV-tPA 治疗后 MT 使用率和患者特征的变化趋势。
2013 年至 2018 年期间,我们在全国住院患者数据库中检索接受急性缺血性脑卒中机械取栓的患者。比较单独接受机械取栓的患者与 MT+IV-tPA 治疗的患者。采用 Cochran-Armitage 检验评估整个队列以及非白人和白人患者住院期间单独使用机械取栓的趋势。所有估计值均使用出院权重进行了全国化。
共纳入 89645 例接受机械取栓治疗急性缺血性脑卒中的加权住院患者。其中,59935 例(66.9%)患者接受单独机械取栓治疗。单独使用机械取栓的趋势每年增加 3.26%(趋势:<0.001)。关于患者特征的多变量回归分析表明,与白人患者相比,黑人(OR=0.83,=0.001)或西班牙裔(OR=0.79;<0.001)患者更有可能接受单独机械取栓治疗。单独接受机械取栓治疗的非白人和白人之间的斜率没有统计学差异(趋势:有利于非白人的 0.93%;=0.096)。
我们的研究结果表明,在急性缺血性脑卒中患者中,单独使用机械取栓的比例高于 MT+IV-tPA。尽管这种差距正在缩小,但多年来,白人和非白人之间的差异仍然存在。